Lexicon Pharmaceuticals Inc.

Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009.
Clinical Trials Week; 12/7/2009; 688 words; Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX...Pharmaceuticals, Inc.). A summary of...Syndrome, Lexigen Pharmaceuticals Corporation, Pharmaceutical Business, Pharmaceutical...Lexicon Pharmaceuticals Inc. This article was...

Study findings from T. Dekoning et al broaden understanding of epilepsy.
Health & Medicine Week; 12/7/2009; 753 words; ...Reception and production of lexicon (vocabulary) and syntax...increase, and in receptive lexicon and productive syntax...development of productive lexicon was remarkably slow...Blackwell Publishing, Inc., Commerce Place...Lobectomy, Pediatrics, Pharmaceuticals, Pharmacological...

Reportlinker Adds Picture Archiving & Communication Systems (PACS) - A Global Update of Market Trends & Opportunities.
PR Newswire; 12/2/2009; 3345 words; ...technology for healthcare departments, pharmaceutical companies and academic institutions...Trends & Opportunities" by BizAcumen, Inc. Our reports are designed to be most...Delivery Systems 13 Telemedicine Enters the Lexicon of Medical World 14 Electronic Health...

Lexicon Announces Positive Phase 2 Results of LX1031 in Non-Constipating Irritable Bowel Syndrome.(Financial report)
Clinical Trials Week; 11/23/2009; 1112 words; Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) announced...Irritable Bowel Syndrome, Lexigen Pharmaceuticals Corporation, Pharmaceutical Business, Pharmaceutical...Lexicon Pharmaceuticals Inc. This article was prepared...

Clinic Roundup.
BIOWORLD Today; 11/16/2009; 948 words; o Adeona Pharmaceuticals Inc., of Ann Arbor, Mich., said...of 2011. o Esperion Therapeutics Inc., of Plymouth, Mich., started...exocrine pancreatic insufficiency. o Lexicon Pharmaceuticals Inc., of The Woodlands, Texas, reported...